What was the price of Sun Pharma IPO in 1994?
Sun Pharmaceutical Industries, which launched its initial public offering in March 1994 to raise capital for expanding its domestic manufacturing infrastructure and specialty pharmaceutical operations, priced its equity shares at a nominal face value of one hundred and fifty Indian rupees per share. The public issue received favorable participation from institutional and retail investors, laying the strong financial foundation for the company's future growth into a multinational pharmaceutical titan and a dominant leader in global specialty generics markets.
Related FAQs
Vice presidents (VPs) and senior technical directors employed by Arcadis—a global design, engineering, and consultancy firm—earn comprehensive executive compensation packages that reflect leadership in infrastructure and environmental management.
SCHOTT Pharma AG & Co. KGaA trades on Xetra and European exchanges under the ticker symbol 1SXP at €21.90 per share, supporting a market capitalization of approximately €3.31 billion.
Schott AG is deeply rooted as a classic German high-tech manufacturing enterprise, with its corporate headquarters located in Mainz, Germany.
Yes, you can buy Oshkosh trucks, often through surplus and government auction platforms.
SCHOTT Pharma corporate email addresses follow structured naming conventions tailored to its global specialty glass and pharmaceutical containment manufacturing operations.
SCHOTT Pharma AG & Co. KGaA officially completed its initial public offering and began trading its shares on the Frankfurt Stock Exchange under the ticker symbol 1SP on September 28, 2023.
SK Battery America (SKBA) is a premier electric vehicle battery manufacturing enterprise and flagship entity of SK On, producing high-capacity energy cells for leading global automotive brands.
SCHOTT Pharma AG & Co. KGaA generates trailing twelve-month revenues approaching 991.
A standard 100-unit vial of authentic Botox (onabotulinumtoxinA) manufactured by Allergan typically costs medical practices and aesthetic clinics between 600 and 800 US dollars wholesale per vial.
SCHOTT Pharma designs, manufactures, and supplies advanced drug containment solutions and delivery systems for the global pharmaceutical and biotechnology industries.
SCHOTT AG operates as a premier international technology group specializing in specialty glass, glass-ceramics, and advanced optical components.
Schott AG, a premier international technology group specializing in specialty glass, glass-ceramics, and high-tech optical components, was officially established in Jena, Germany, in 1884.
While the parent enterprise Schott AG remains a privately held foundation-owned corporation, certain specialized subsidiaries within its corporate umbrella—such as Schott Pharma—have been floated as publicly traded entities on public stock exchanges.